GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Callitas Health Inc (OTCPK:MPHMF) » Definitions » Net Cash per Share

Callitas Health (Callitas Health) Net Cash per Share : $-0.10 (As of Sep. 2020)


View and export this data going back to 2008. Start your Free Trial

What is Callitas Health Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Callitas Health's Net Cash per Share for the quarter that ended in Sep. 2020 was $-0.10.

The historical rank and industry rank for Callitas Health's Net Cash per Share or its related term are showing as below:

MPHMF's Price-to-Net-Cash is not ranked *
in the Biotechnology industry.
Industry Median: 3.96
* Ranked among companies with meaningful Price-to-Net-Cash only.

Callitas Health Net Cash per Share Historical Data

The historical data trend for Callitas Health's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Callitas Health Net Cash per Share Chart

Callitas Health Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.37 -0.10 -0.11 -0.12 -0.09

Callitas Health Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.09 -0.09 -0.10 -0.10

Competitive Comparison of Callitas Health's Net Cash per Share

For the Biotechnology subindustry, Callitas Health's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Callitas Health's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Callitas Health's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Callitas Health's Price-to-Net-Cash falls into.



Callitas Health Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Callitas Health's Net Cash per Share for the fiscal year that ended in Dec. 2019 is calculated as

Net Cash per Share (A: Dec. 2019 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.011-4.174-0)/45.272
=-0.09

Callitas Health's Net Cash per Share for the quarter that ended in Sep. 2020 is calculated as

Net Cash per Share (Q: Sep. 2020 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.017-4.537-0)/45.272
=-0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Callitas Health  (OTCPK:MPHMF) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Callitas Health Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Callitas Health's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Callitas Health (Callitas Health) Business Description

Traded in Other Exchanges
N/A
Address
734 - 1055 Dunsmuir Street, Vancouver, BC, CAN, V7X 1B1
Callitas Health Inc is a clinical-stage company. It is engaged in developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The company's products offering includes ToConceive, C-103 Reformulated Orlistat, and Extrinsa. ToConceive is a fertility enhancing moisturizer. It is clinically proven to increase a woman's own natural conception lubrication, called transudate, to aid in conception. Orlistat is FDA-approved for weight management and sold by Roche as Xenical (prescription) and by GlaxoSmithKline as alli. Extrinsa focuses on women with orgasm and arousal difficulties. The topical, local, and the non-systemic product is also non-hormonal and does not affect the central nervous system.